Treatment of skeletal voids with implantable substrate hydrated with bone marrow concentrate

US10751185B2 · kind B2 · utility

Assignee

• SpineSmith Partners, L.P. · US

Inventors

• Eileen Dawson · Austin, US
• Kevin Dunworth · Austin, US
• Theodore Sand · Austin, US
• Matthew Murphy · Austin, US
• John B. Rossman · Austin, US
• Melissa Samano · Austin, US
• Richard Suzuki · Austin, US
• Kathryn Moncivais · Austin, US

Key dates

• Filing date: May 30, 2016
• Grant date: Aug 25, 2020
• Expiry date: Dec 15, 2036

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61L2430/02
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

The invention is directed to a bone void filler comprising a scaffold or matrix. The scaffold or matrix may include a porous inorganic matrix component and/or a 3D-printed implantable device. The bone void filler may include a cellular component containing cells, some of which are capable of making extracellular matrix resembling native bone tissue. The bone void filler may include an organic matrix, such as, an organic biopolymer that aids in cell retention and renders the scaffold or matrix moldable. The bone void filler may include growth factors and/or cytokines. The bone void filler may include a clotting agent.